Defects in Surfactant Synthesis: Clinical Implications

Pediatric Clinics of North America

Volumn 53, Issue 5, 2006, Pages 911-927

  Cole, F Sessions ^a   Nogee, Lawrence M ^b   Hamvas, Aaron ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GLUCOCORTICOID; HYDROXYCHLOROQUINE; LUNG SURFACTANT; SURFACTANT; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

AUTOPSY; BREATHING PATTERN; CLEARANCE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; GENE CONTROL; GENE MUTATION; GENETIC DISORDER; GENOMICS; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; HUMAN; LUNG PERFUSION; LUNG TRANSPLANTATION; LUNG VENTILATION; METABOLISM; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATHOLOGY; PROGNOSIS; PROTEIN DEFICIENCY; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; REVIEW; SECRETION; SYNTHESIS; TREATMENT OUTCOME;

HUMANS; INFANT, NEWBORN; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 33749259851     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2006.08.006     Document Type: Review

References (115)

1. Guyer B., Freedman M.A., Strobino D.M., et al. Annual summary of vital statistics: trends in the health of Americans during the 20th century. Pediatrics 106 6 (2000) 1307-1317
2. Hoyert D., Freedman M.A., Strobino D.M., et al. Annual summary of vital statistics: 2000. Pediatrics 108 6 (2001) 1241-1255
3. Arias E., MacDorman M.F., Strobino D.M., et al. Annual summary of vital statistics: 2002. Pediatrics 112 6 Pt 1 (2003) 1215-1230
4. Jobe A.H., and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 7 (2001) 1723-1729
5. Ireys H., Anderson G.F., Shaffer T.J., et al. Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993. Pediatrics 100 2 Pt 1 (1997) 197-204
6. Angus D., Linde-Zwirble W.T., Clermont G., et al. Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am J Respir Crit Care Med 164 7 (2001) 1154-1160
7. van der Deen M., de Vries E.G., Timens W., et al. ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res 6 1 (2005) 59
8. Hartl D., and Griese M. Interstitial lung disease in children-genetic background and associated phenotypes. Respir Res 6 1 (2005) 32
9. Avery M., and Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 97 5, Pt 1 (1959) 517-523
10. Clements J.A. Lung surfactant: a personal perspective. Annu Rev Physiol 59 (1997) 1-21
11. Clements J.A., and Avery M.E. Lung surfactant and neonatal respiratory distress syndrome. Am J Respir Crit Care Med 157 4 Pt 2 (1998) S59-S66
12. Whitsett J.A., and Stahlman M.T. Impact of advances in physiology, biochemistry, and molecular biology on pulmonary disease in neonates. Am J Respir Crit Care Med 157 4 Pt 2 (1998) S67-S71
13. Haller T., Ortmayr J., Friedrich F., et al. Dynamics of surfactant release in alveolar type II cells. Proc Natl Acad Sci USA 95 4 (1998) 1579-1584
14. Clements J.A. Functions of the alveolar lining. Am Rev Respir Dis 115 6 Pt 2 (1977) 67-71
15. King R.J., and Clements J.A. Surface active materials from dog lung. II. Composition and physiological correlations. Am J Physiol 223 3 (1972) 715-726
16. Ingenito E.P., Mora R., and Mark L. Pivotal role of anionic phospholipids in determining dynamic behavior of lung surfactant. Am J Respir Crit Care Med 161 3 Pt 1 (2000) 831-838
17. Veldhuizen R., Nag K., Orgeig S., et al. The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1408 2-3 (1998) 90-108
18. Whitsett J.A., and Weaver T.E. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 347 26 (2002) 2141-2148
19. Shulenin S., Nogee L.M., Annilo T., et al. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 350 13 (2004) 1296-1303
20. Clark D.A., Pincus L.G., Oliphant M., et al. HLA-A2 and chronic lung disease in neonates. JAMA 248 15 (1982) 1868-1869
21. Clark J.C., Wert S.E., Bachurski C.J., et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 92 17 (1995) 7794-7798
22. Clark J.C., Weaver T.E., Iwamoto H.S., et al. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice. Am J Respir Cell Mol Biol 16 1 (1997) 46-52
23. Evans M., Palta M., Sadek M., et al. Associations between family history of asthma, bronchopulmonary dysplasia, and childhood asthma in very low birth weight children. Am J Epidemiol 148 5 (1998) 460-466
24. Floros J., Veletza S.V., Kotikalapudi P., et al. Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J 305 Pt 2 (1995) 583-590
25. Floros J., DiAngelo S., Koptides M., et al. Human SP-A locus: allele frequencies and linkage disequilibrium between the two surfactant protein A genes. Am J Respir Cell Mol Biol 15 4 (1996) 489-498
26. Floros J., and Kala P. Surfactant proteins: molecular genetics of neonatal pulmonary diseases. Annu Rev Physiol 60 (1998) 365-384
27. Fujikura T., and Froehlich L.A. The influence of race and other factors on pulmonary hyaline membranes. A report from the Collaborative Study of Cerebral Palsy. Am J Obstet Gynecol 95 4 (1966) 572-578
28. Hulsey T.C., Alexander G.R., Robillard P.Y., et al. Hyaline membrane disease: the role of ethnicity and maternal risk characteristics. Am J Obstet Gynecol 168 2 (1993) 572-576
29. Jaskoll T., Hu C.C., and Melnick M. Mouse major histocompatibility complex and lung development: haplotype variation, H-2 immunolocalization, and progressive maturation. Am J Med Genet 39 4 (1991) 422-436
30. Kala P., Koptides M., Diangelo S., et al. Characterization of markers flanking the human SP-B locus. Dis Markers 13 3 (1997) 153-167
31. Kala P., Ten Have T., Nielsen H., et al. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr Res 43 2 (1998) 169-177
32. Karinch A.M., deMello D.E., and Floros J. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans. Biochem J 321 Pt 1 (1997) 39-47
33. Korfhagen T.R., Bruno M.D., Ross G.F., et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 93 18 (1996) 9594-9599
34. McCormick S.M., Boggaram V., and Mendelson C.R. Characterization of mRNA transcripts and organization of human SP-A1 and SP-A2 genes. Am J Physiol 266 4 Pt 1 (1994) L354-L366
35. Miller H.C., and Futrakul P. Birth weight, gestational age, and sex as determining factors in the incidence of respiratory distress syndrome of prematurely born infants. J Pediatr 72 5 (1968) 628-635
36. Mason R.J., Greene K., and Voelker D.R. Surfactant protein A and surfactant protein D in health and disease. Am J Physiol 275 1 Pt 1 (1998) L1-L13
37. Perelman R.H., Palta M., Kirby R., et al. Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics 78 2 (1986) 238-244
38. Richardson D.K., and Torday J.S. Racial differences in predictive value of the lecithin/sphingomyelin ratio. Am J Obstet Gynecol 170 5 Pt 1 (1994) 1273-1278
39. Robillard P.Y., Hulsey T.C., Alexander G.R., et al. Hyaline membrane disease in black newborns: does fetal lung maturation occur earlier?. Eur J Obstet Gynecol Reprod Biol 55 3 (1994) 157-161
40. Tokieda K., Whitsett J.A., Clark J.C., et al. Pulmonary dysfunction in neonatal SP-B-deficient mice. Am J Physiol 273 4 Pt 1 (1997) L875-L882
41. Veletza S.V., Rogan P.K., Ten Have T., et al. Racial differences in allelic distribution at the human pulmonary surfactant protein B gene locus (SP-B). Exp Lung Res 22 4 (1996) 489-494
42. Ikegami M., Korfhagen T.R., Whitsett J.A., et al. Characteristics of surfactant from SP-A-deficient mice. Am J Physiol 275 2 Pt 1 (1998) L247-L254
43. Weaver T.E., and Conkright J.J. Function of surfactant proteins B and C. Annu Rev Physiol 63 (2001) 555-578
44. Hallman M. Lung surfactant, respiratory failure, and genes. N Engl J Med 350 13 (2004) 1278-1280
45. Nogee L.M., Dunbar III A.E., Wert S.E., et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344 8 (2001) 573-579
46. Nogee L.M., de Mello D.E., Dehner L.P., et al. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 328 6 (1993) 406-410
47. Rodriguez R.J. Management of respiratory distress syndrome: an update. Respir Care 48 3 (2003) 279-286 [discussion: 286-7]
48. Merrill J.D., and Ballard R.A. Pulmonary surfactant for neonatal respiratory disorders. Curr Opin Pediatr 15 2 (2003) 149-154
49. Avery M.E., Tooley W.H., Keller J.B., et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79 1 (1987) 26-30
50. McColley S. Bronchopulmonary dysplasia. Impact of surfactant replacement therapy. Pediatr Clin N Amer 45 (1998) 573-586
51. Finer N. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome. Paediatr Resp Rev 5 Suppl A (2004) S289-S297
52. Smith V.C., Zupancic J.A., McCormick M.C., et al. Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr 146 4 (2005) 469-473
53. Parker R.A., Lindstrom D.P., and Cotton R.B. Evidence from twin study implies possible genetic susceptibility to bronchopulmonary dysplasia. Semin Perinatol 20 3 (1996) 206-209
54. Cole F., Hamvas A., and Nogee L.M. Genetic disorders of neonatal respiratory function. Pediatr Res 50 2 (2001) 157-162
55. Hamvas A., Wise P.H., Yang R.K., et al. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites. N Engl J Med 334 25 (1996) 1635-1640
56. Frisbie W., Song S.E., Powers D.A., et al. The increasing racial disparity in infant mortality: respiratory distress syndrome and other causes. Demography 41 4 (2004) 773-800
57. Nogee L.M. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu Rev Physiol 66 (2004) 601-623
58. Cheong N., Madesh M., Gonzales L.W., et al. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J Biol Chem 281 14 (2006) 9791-9800
59. Garmany T.H., Moxley M.A., White F.V., et al. Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res 59 (2006) 801-805
60. Bullard J.E., Wert S.E., Whitsett J.A., et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 172 8 (2005) 1026-1031
61. Hamvas A. Surfactant protein B deficiency: insights into inherited disorders of lung cell metabolism. Curr Probl Pediatr 27 9 (1997) 325-345
62. Nogee L.M., Garnier G., Dietz H.C., et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93 4 (1994) 1860-1863
63. Hawgood S., Derrick M., and Poulain F. Structure and properties of surfactant protein B. Biochim Biophys Acta 1408 2-3 (1998) 150-160
64. Nogee L.M., Wert S.E., Proffit S.A., et al. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 161 3 Pt 1 (2000) 973-981
65. Cole F.S., Hamvas A., Rubinstein P., King E., Trusgnich M., Nogee L.M., et al. Population-based estimates of surfactant protein B deficiency. Pediatrics 105 3 Pt 1 (2000) 538-541
66. Hamvas A., Trusgnich M.A., Brice H., et al. Population-based screening for rare mutations: high-throughput DNA extraction and molecular amplification from Guthrie cards. Pediatr Res 50 5 (2001) 666-668
67. Li J., Hosia W., Hamvas A., et al. N-terminally extended surfactant protein (SP) C isolated from SP-B-deficient children has reduced surface activity and inhibited lipopolysaccharide binding. Biochemistry 43 13 (2004) 3891-3898
68. Hamvas A., Nogee L.M., Mallory Jr. G.B., et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 130 2 (1997) 231-239
69. Beers M.F., Hamvas A., Moxley M.A., et al. Pulmonary surfactant metabolism in infants lacking surfactant protein B. Am J Respir Cell Mol Biol 22 3 (2000) 380-391
70. Ballard P.L., Nogee L.M., Beers M.F., et al. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics 96 6 (1995) 1046-1052
71. Klein J.M., Thompson M.W., Snyder J.M., et al. Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr 132 2 (1998) 244-248
72. Dunbar III A.E., Wert S.E., Ikegami M., et al. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr Res 48 3 (2000) 275-282
73. Ballard P.L., Merrill J.D., Godinez R.I., et al. Surfactant protein profile of pulmonary surfactant in premature infants. Am J Respir Crit Care Med 168 9 (2003) 1123-1128
74. Merrill J.D., Ballard R.A., Cnaan A., et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 56 6 (2004) 918-926
75. Melton K.R., Nesslein L.L., Ikegami M., et al. SP-B deficiency causes respiratory failure in adult mice. Am J Physiol Lung Cell Mol Physiol 285 3 (2003) L543-L549
76. Tokieda K., Ikegami M., Wert S.E., et al. Surfactant protein B corrects oxygen-induced pulmonary dysfunction in heterozygous surfactant protein B-deficient mice. Pediatr Res 46 6 (1999) 708-714
77. Tokieda K., Iwamoto H.S., Bachurski C., et al. Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol 21 4 (1999) 463-472
78. Yusen R.D., Cohen A.H., and Hamvas A. Normal lung function in subjects heterozygous for surfactant protein-B deficiency. Am J Respir Crit Care Med 159 2 (1999) 411-414
79. Cole F.S. Surfactant protein B: unambiguously necessary for adult pulmonary function. Am J Physiol Lung Cell Mol Physiol 285 3 (2003) L540-L542
80. Amin R., Wert S.E., Baughman R.P., et al. Surfactant protein deficiency in familial interstitial lung disease. J Pediatr 139 1 (2001) 85-92
81. Thomas A.Q., Lane K., Phillips III J., et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 165 9 (2002) 1322-1328
82. Hamvas A., Nogee L.M., White F.V., et al. Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene. Am J Respir Cell Mol Biol 30 6 (2004) 771-776
83. Chibbar R., Shih F., Baga M., et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod Pathol 17 8 (2004) 973-980
84. Tredano M., Griese M., Brasch F., et al. Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet A 126 1 (2004) 18-26
85. Nogee L.M., Dunbar A.E., Askin F., et al. Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest 121 3 Suppl (2002) 20S-21S
86. Beers M.F., and Mulugeta S. Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol 67 (2005) 663-696
87. Stevens P.A., Pettenazzo A., Brasch F., et al. Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal proprotein trafficking resulting from a spontaneous mutation in the surfactant protein C gene. Pediatr Res 57 1 (2005) 89-98
88. Lahti M., Marttila R., and Hallman M. Surfactant protein C gene variation in the Finnish population - association with perinatal respiratory disease. Eur J Hum Genet 12 4 (2004) 312-320
89. Nogee L.M. Abnormal expression of surfactant protein C and lung disease. Am J Respir Cell Mol Biol 26 6 (2002) 641-644
90. Glasser S.W., Burhans M.S., Korfhagen T.R., et al. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci USA 98 11 (2001) 6366-6371
91. Glasser S.W., Detmer E.A., Ikegami M., et al. Pneumonitis and emphysema in sp-C gene targeted mice. J Biol Chem 278 16 (2003) 14291-14298
92. Perez-Gil J., and Keough K.M. Interfacial properties of surfactant proteins. Biochim Biophys Acta 1408 2-3 (1998) 203-217
93. Johansson J. Structure and properties of surfactant protein C. Biochim Biophys Acta 1408 2-3 (1998) 161-172
94. Bridges J.P., Wert S.E., Nogee L.M., et al. Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J Biol Chem 278 52 (2003) 52739-52746
95. Mulugeta S., and Beers M.F. Processing of surfactant protein C requires a type II transmembrane topology directed by juxtamembrane positively charged residues. J Biol Chem 278 48 (2003) 47979-47986
96. Wang W., Mulugeta S., Russo S.J., et al. Deletion of exon 4 from human surfactant protein C results in aggregosome formation and generation of a dominant negative. J Cell Sci 116 (2003) 683-692
97. Kabore A.F., Wang W.J., Russo S.J., et al. Biosynthesis of surfactant protein C: characterization of aggresome formation by EGFP chimeras containing propeptide mutants lacking conserved cysteine residues. J Cell Sci 114 Pt 2 (2001) 293-302
98. Mulugeta S., Nguyen V., Russo S.J., et al. A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am J Respir Cell Mol Biol 32 6 (2005) 521-530
99. Hampton R.Y. ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 14 4 (2002) 476-482
100. Oyadomari S., Araki E., and Mori M. Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 7 4 (2002) 335-345
101. Patil C., and Walter P. Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr Opin Cell Biol 13 3 (2001) 349-355
102. Zhang K., and Kaufman R.J. Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 279 25 (2004) 25935-25938
103. Niwa M., and Walter P. Pausing to decide. Proc Natl Acad Sci USA 97 23 (2000) 12396-12397
104. Johnson A.L., Braidotti P., Pietra G.G., et al. Post-translational processing of surfactant protein-C proprotein: targeting motifs in the NH(2)-terminal flanking domain are cleaved in late compartments. Am J Respir Cell Mol Biol 24 3 (2001) 253-263
105. Brasch F., Schimanski S., Muhlfeld C., et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med 174 5 (2006) 571-580
106. Dean M., Hamon Y., and Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42 7 (2001) 1007-1017
107. Holland P.M., Abramson R.D., Watson R., et al. Detection of specific polymerase chain reaction product by utilizing the 5′--3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 88 16 (1991) 7276-7280
108. Whitsett J.A., Wert S.E., and Xu Y. Genetic disorders of surfactant homeostasis. Biol Neonate 87 4 (2005) 283-287
109. Hamvas A., Cole F.S., deMello D.E., et al. Surfactant protein B deficiency: antenatal diagnosis and prospective treatment with surfactant replacement. J Pediatr 125 3 (1994) 356-361
110. Palomar L, Nogee LM, Sweet SC, et al. Long-term outcomes after infant lung transplantation for surfactant protein B deficiency related to other causes of respiratory failure. J Pediatr, in press.
111. Rosen D.M., and Waltz D.A. Hydroxychloroquine and surfactant protein C deficiency. N Engl J Med 352 2 (2005) 207-208
112. Sweet S.C. Pediatric lung transplantation: update 2003. Pediatr Clin North Am 50 6 (2003) 1393-1417 [ix]
113. Harmon W.E., McDonald R.A., Reyes J.D., et al. Pediatric transplantation, 1994-2003. Am J Transplant 5 4 Pt 2 (2005) 887-903
114. Meyers B.F., de la Morena M., Sweet S.C., et al. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg 129 6 (2005) 1421-1429
115. Deterding R., and Fan L.L. Surfactant dysfunction mutations in children's interstitial lung disease and beyond. Am J Respir Crit Care Med 172 8 (2005) 940-941